 Cardiovascular Diseases
"Cardiovascular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Descriptor ID |
D002318
|
| MeSH Number(s) |
C14
|
| Concept/Terms |
Cardiovascular Diseases- Cardiovascular Diseases
- Cardiovascular Disease
- Disease, Cardiovascular
- Diseases, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Diseases".
This graph shows the total number of publications written about "Cardiovascular Diseases" by people in this website by year, and whether "Cardiovascular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 | | 1997 | 1 | 3 | 4 | | 1998 | 1 | 2 | 3 | | 1999 | 6 | 1 | 7 | | 2000 | 5 | 2 | 7 | | 2001 | 6 | 3 | 9 | | 2002 | 11 | 4 | 15 | | 2003 | 14 | 8 | 22 | | 2004 | 17 | 5 | 22 | | 2005 | 18 | 5 | 23 | | 2006 | 20 | 22 | 42 | | 2007 | 30 | 13 | 43 | | 2008 | 42 | 10 | 52 | | 2009 | 33 | 14 | 47 | | 2010 | 31 | 13 | 44 | | 2011 | 43 | 23 | 66 | | 2012 | 54 | 20 | 74 | | 2013 | 52 | 14 | 66 | | 2014 | 36 | 17 | 53 | | 2015 | 58 | 20 | 78 | | 2016 | 48 | 21 | 69 | | 2017 | 48 | 15 | 63 | | 2018 | 58 | 24 | 82 | | 2019 | 65 | 27 | 92 | | 2020 | 75 | 14 | 89 | | 2021 | 66 | 10 | 76 | | 2022 | 93 | 2 | 95 | | 2023 | 79 | 4 | 83 | | 2024 | 68 | 31 | 99 | | 2025 | 75 | 7 | 82 | | 2026 | 29 | 3 | 32 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
Fleg JL, Golbus JR, Afilalo J, Cornwell WK, Cuccurullo S, Dougherty CM, Forman DE, Huffman KM, Khadanga S, Mancini D, Nytrøen K, Reeves GR, Taylor JA. Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart Association. Circulation. 2026 Aug 25; 154(8):e319-e338.
-
Cornwell WK, Dineen EH, Petek BJ, Shafer KM, Davenport E, Chung EH, Kim JH, Levine BD. Sports and Exercise Cardiology: A New Frontier in Cardiovascular Disease Management. Circ Popul Health Outcomes. 2026 Aug; 19(8):e013583.
-
DiDomenico RJ, Marrs JC, Bress AP, Denfeld QE, Dobesh PP, Effron MB, Goyal P, Onyebeke C, Peterson JK, Petrovic M. Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association. Circulation. 2026 Aug 25; 154(8):e299-e318.
-
Nicholls SJ, Nelson AJ, Ray KK, Ditmarsch M, Kling D, Hsieh A, Szarek M, Kastelein JJ, Davidson MH. Obicetrapib and lipoprotein(a) levels in patients at high cardiovascular risk: a pooled analysis of trials. Eur Heart J. 2026 Jul 07; 47(26):3404-3414.
-
Fort MP, Haapanen KA, Aulakh A, Moreland J, Sanders T, Dardouri M, Bauer KL, Broaddus-Shea E, Glasgow RE, Mays GP, Kumanyika S, Henderson K. Assessing Cardiovascular Disease Prevention Activities in the Denver, Colorado, Metropolitan Area: Building on an Existing Network to Enhance Emphasis on Equity. Am J Public Health. 2026 07; 116(S3):S152-S161.
-
Huang SP, Su CC, Nethery R, Josey K, Bates B, Robinson D, Gandhi P, Rua M, Parthasarathi A, Setoguchi S, Yang YK. A Drug-Environment Interaction Between PM2.5 Concentration and Corticosteroid Use on Cardiovascular and Thromboembolic Events in Older Adults. Pharmacoepidemiol Drug Saf. 2026 Jul; 35(7):e70414.
-
Barac A, Guha A, Fleming TR, Bonaca M, Thavendiranathan P, Deswal A, Amiri-Kordestani L, Bhatnagar V, Cordoba R, Hurvitz S, Adjei AA, Agarwal N. Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association. Circulation. 2026 Aug 04; 154(5):e188-e205.
-
Barac A, Guha A, Fleming TR, Bonaca M, Thavendiranathan P, Deswal A, Amiri-Kordestani L, Bhatnagar V, Cordoba R, Hurvitz S, Adjei AA, Agarwal N. Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association. J Clin Oncol. 2026 Aug; 44(22):2140-2155.
-
Khan SS, Ndumele CE, Bhave N, Blumenthal RS, Coresh J, Huang X, Joseph JJ, Khera A, Ho JE, Lloyd-Jones DM, Low Wang CC, Lu Y, Morris PB, Nasir K, Natarajan P, Rangaswami J, Rodriguez F, Sperling LS, Virani SS, Zhang S. Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2026 Aug 04; 88(5):589-612.
-
Khan SS, Bhave N, Blumenthal RS, Coresh J, Huang X, Joseph JJ, Khera A, Ho JE, Lloyd-Jones DM, Low Wang CC, Lu Y, Morris PB, Nasir K, Natarajan P, Rangaswami J, Rodriguez F, Sperling LS, Virani SS, Zhang S, Ndumele CE. Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2026 Jul 28; 154(4):e159-e180.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|